| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Australia | 2 | |
| #4 | Mexico | 2 | |
| #5 | South Africa | 2 | |
| #6 | Brazil | 1 | |
| #7 | Canada | 1 | |
| #8 | China | 1 | |
| #9 | Republic of Korea | 1 | |
| #10 | Singapore | 1 | |
| #11 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Acyclic or carbocyclic compounds | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Khanna Ish | 10 |
| #2 | Pillarisetti Sivaram | 10 |
| #3 | Saxena Uday | 8 |
| #4 | Kallam Anji Reddy | 5 |
| #5 | Akella Venkateswarlu | 4 |
| #6 | Akella Venkateswarulu | 4 |
| #7 | Reddy Anji Reddy | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2013035053A2 | Novel conjugation-facilitated transport of drugs across blood brain barrier | |
| WO2012090104A1 | Methods and compositions for designing novel conjugate therapeutics | |
| KR20140009125A | Methods and compositions for treatment of diabetes and dyslipidemia | |
| EP2528898A2 | NOVEL COMPOSITIONS FOR REDUCING Aß 42 PRODUCTION AND THEIR USE IN TREATING ALZHEIMER'S DISEASE (AD) | |
| EP2310004A1 | Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |